表紙
市場調査レポート

患者モニタリング装置/設備/システム市場:製品別(血糖、EEG、ECG、カプノグラフィ、スパイロメーター、睡眠時無呼吸、パルスオキシメータ―、胎児用ドップラーモニター、マルチパラメーター、遠隔、体重、体温)、エンドユーザー別(病院、在宅)の世界市場予測

Patient Monitoring Device/Equipment/System Market by Product (Blood Glucose, EEG, ECG, Capnography, Spirometer, Sleep Apnea, Pulse Oximeter, Fetal Doppler, Ultiparameter, Remote, Weight, Temperature), End-User (Hospitals, Home) - Global Forecast to 2020

発行 MarketsandMarkets 商品コード 239654
出版日 ページ情報 英文 205 Pages
即納可能
価格
本日の銀行送金レート: 1USD=104.18円で換算しております。
Back to Top
患者モニタリング装置/設備/システム市場:製品別(血糖、EEG、ECG、カプノグラフィ、スパイロメーター、睡眠時無呼吸、パルスオキシメータ―、胎児用ドップラーモニター、マルチパラメーター、遠隔、体重、体温)、エンドユーザー別(病院、在宅)の世界市場予測 Patient Monitoring Device/Equipment/System Market by Product (Blood Glucose, EEG, ECG, Capnography, Spirometer, Sleep Apnea, Pulse Oximeter, Fetal Doppler, Ultiparameter, Remote, Weight, Temperature), End-User (Hospitals, Home) - Global Forecast to 2020
出版日: 2016年01月18日 ページ情報: 英文 205 Pages
概要

近年患者モニタリング装置は、医療現場で必要不可欠の要素となっています。技術の進歩による装置の小型化が急速に進むなか、離れた場所から患者の状態を監視することで医師の往診回数を減らすためのシステムなど用途も広がっています。2015年の患者モニタリング市場で最大のシェアを有していたのは、心電計を中心とした心臓モニタリング装置であり、今後も心臓病や糖尿病、高血圧などの患者が増えると予想されることから、2020年の時点でもトップシェアを維持すると思われます。心臓モニタリング装置に次いで大きなシェアを有しているのは、さまざまな生理学的パラメーターの監視が可能なマルチパラメーターモニタリング装置であり、入院件数の増加という事態を受け、多くの病院がこのシステムへの投資を強化しています。一方、今後急速に成長すると見られているのが、神経変性疾患や呼吸器疾患に対応するモニタリング装置の市場であり、とりわけ呼気中の二酸化炭素濃度を測定するカプノグラフィは急成長が見込まれます。

当レポートは、着実に成長を続ける世界の患者モニタリング装置市場を分析し、定性的データや市場規模、各分野の成長見通し、競合状況などを明らかにするとともに、2020年までの見通しを示したもので、主要企業のプロファイルで各社の基本的なデータや戦略なども紹介します。

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 主な調査結果

  • 2020年まで着実な成長が見込まれる患者モニタリング市場
  • 製品別の患者モニタリング市場
  • 製品別および地域別の患者モニタリング市場

第5章 市場の概況

  • イントロダクション
  • 市場の力学
    • 成長促進要因
    • 成長阻害要因
    • ビジネスチャンス
    • 課題

第6章 血行動態モニタリング装置

  • イントロダクション
    • 血圧モニター
    • 血糖モニター
    • 血液ガスと電解質の分析装置
    • コレステロール分析装置

第7章 神経モニタリング装置

  • イントロダクション
    • 脳波計 (EEG)
    • 経頭蓋ドップラー (ECD)
    • 脳磁計 (MEG)
    • 脳酸素飽和度モニタリング装置
    • 頭蓋内圧モニタリング装置 (ICP)

第8章 心臓モニタリング装置

  • イントロダクション
  • 心電計 (ECG)
  • 製品タイプ別心電計市場
    • 安静時心電計
    • 有線ホルター心電計
    • 無線ホルター心電計
  • リードタイプ別心電計市場
    • シングルリード装置
    • 3-6リード装置
    • 12リード装置
  • イベントモニター
  • 製品タイプ別イベントモニター市場
    • 発症前
    • 発症後
  • 技術別イベントモニター市場
    • 自動検知モニター
    • 手動イベントモニター
  • 埋め込み式ループレコーダー
  • 心拍出量モニタリング装置
    • 低侵襲性装置
    • 非侵襲性装置

第9章 胎児および新生児のモニタリング装置

  • イントロダクション
  • 超音波胎児ドップラーモニター
  • 子宮内胎児モニタリング装置

第10章 呼吸モニタリング装置

  • イントロダクション
  • カプノグラフィ
  • スパイロメーター
  • 麻酔モニタリング装置
  • 睡眠時無呼吸モニタリング装置
  • パルス酸素濃度計

第11章 マルチパラメーターモニタリング装置

  • イントロダクション
  • 高感度モニター
  • 中感度モニター
  • 低感度モニター

第12章 遠隔患者モニタリング装置市場

  • イントロダクション

第13章 体重モニタリング装置

  • イントロダクション

第14章 体温モニタリング装置

  • イントロダクション

第15章 地域別の患者モニタリング装置市場

  • イントロダクション
  • 北米
  • 欧州
  • アジア太平洋
  • 他の地域

第16章 競合状況

  • 概要
  • 市場シェア分析
    • 血行動態モニタリング装置
    • 神経モニタリング装置
    • 心臓モニタリング装置
    • 呼吸モニタリング装置
    • 胎児および新生児のモニタリング装置
    • マルチパラメーターモニタリング装置
  • 競合状況とトレンド
    • 新製品の投入と承認
    • 協定、提携、協力
    • 買収と事業拡大
    • その他の動き

第17章 企業プロファイル

  • イントロダクション
  • ABBOTT LABORATORIES
  • ROCHE DIAGNOSTICS
  • SIEMENS HEALTHCARE
  • GE HEALTHCARE
  • MEDTRONIC PLC
  • PHILIPS HEALTHCARE
  • LIFEWATCH AG
  • 日本光電
  • オムロン
  • HONEYWELL INTERNATIONAL, INC.

第18章 付録

図表リスト

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: MD 2436

Attributed to the Rising Prevalence of Neuro-degenerative Diseases, the Patient Monitoring Market in the Neuromonitoring Segment Will Be the Fastest Growing Segment in the Next Five Years.

The patient monitoring devices market is expected to grow at a CAGR of 5.6% to reach USD 24,762 million by 2020.

The patient monitoring devices form an indispensible part of medical team for every procedure, whether operating in a small clinic or a large multi-specialty hospital. Advanced technology has reduced the size of these monitors drastically with the latest devices being mere grain sized implants. The rising adoption of telemetry and remote monitoring has fueled the growth of patient monitoring devices. The capacity of these devices to monitor patients from long distance, perform intra-operative procedures, and prescribe treatments to patients has reduced discomfort for patients, which has also reduced the hospital stays for patients and reduced the physicians' need to travel.

The cardiac monitors segment had the largest share of the total patient monitoring devices market in 2015 and will continue to grow in the next five years to retain the leading position in 2020. The high growth in this segment is attributed to the growing demand for ECG devices. Moreover, rising incidences of cardiac and diseases such as diabetes and hypertension have also contributed to the largest share of the cardiac monitors market. Multi-parameter monitoring devices market was the second largest segment in 2015. These devices can monitor various physiological parameters of a patient in order to have an overview of the patients' health and status. Due to the tremendous increase in the number of hospitalizations, ranging from extremely serious to basic monitoring, hospitals are increasing the investment in the multi-parameter monitoring devices.

The neuromonitoring devices segment, on the other hand, will be the fastest growing segment in the coming years. With the evolution in technology, neuromonitoring devices can predict the occurrence of neurodegenerative diseases. With growing incidences and increasing awareness of neurodegenerative diseases this market is set to grow at a fast pace. The respiratory monitors segment is also expected to grow at a high pace in the forecast period. Under this segment the capnography products were the fastest growing among all the sub-segments of patient monitoring. Growing number of alternate use of capnographs is the major factor driving the growth of the market. Here the use of capnograph is not limited for intubated patients only but is used for measuring breathing in non-intubated patients. The Remote Patient Monitoring (RPM) devices segment is also poised to grow at a high pace in the coming years, driven by the strict government regulations to restrain the rising healthcare costs.

From an insight perspective, this research report focuses on qualitative data, market size, and growth of various segments and subsegments, competitive landscape, and company profiles. The qualitative data covers various levels of industry analysis such as market dynamics (drivers, restraints, opportunities, and threats). The report also offers market sizes and data of the various segments in this industry. It focuses on emerging and high-growth segments, high-growth regions, and initiatives by governments. The competitive landscape covers the growth strategies adopted by industry players in the last three years. The company profiles comprise basic views on the key players in the patient monitoring devices market and the strategies adopted by them to maintain and increase their market shares in the near future. The above mentioned market research data, current market size, and forecast of the future trends will help key players and new entrants to make the necessary decisions regarding product offerings, geographical focus, change in approach, R&D investments for innovations in products and technologies, and levels of output in order to remain successful.

Reasons to Buy the Report:

This report will enable both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help these firms garner a greater market share. Firms purchasing the report can use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on patient monitoring devices offered by top 10 players in the market. The report analyzes the patent patient monitoring devices market by product and end user across geographies
  • Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and new product launches in the patient monitoring devices market
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various patient monitoring devices across geographies
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the patient monitoring devices market
  • Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of leading players in the patient monitoring devices market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. MARKET SIZE ESTIMATION
  • 2.2. MARKET BREAKDOWN AND DATA TRIANGULATION
    • 2.2.1. KEY DATA FROM SECONDARY SOURCES
    • 2.2.2. KEY DATA FROM PRIMARY SOURCES
      • 2.2.2.1. Key Industry Insights
    • 2.2.3. ASSUMPTIONS

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. PATIENT MONITORING DEVICES MARKET TO GROW AT A STEADY RATE DURING THE FORECAST PERIOD
  • 4.2. PATIENT MONITORING MARKET, BY PRODUCT
  • 4.3. PATIENT MONITORING MARKET, BY PRODUCT & REGION

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET DYNAMICS
    • 5.2.1. DRIVERS
      • 5.2.1.1. Increasing geriatric population to propel the demand for monitoring devices
      • 5.2.1.2. Rising incidence of lifestyle diseases
      • 5.2.1.3. Growing preference for home and remote monitoring
      • 5.2.1.4. Ease-of-use and portability of devices to encourage adoption of point-of-care monitoring devices
    • 5.2.2. RESTRAINTS
      • 5.2.2.1. Dearth of skilled professionals in patient monitoring
    • 5.2.3. OPPORTUNITIES
      • 5.2.3.1. Private institutional nursing
      • 5.2.3.2. Mergers, acquisitions, and joint ventures
    • 5.2.4. CHALLENGES
      • 5.2.4.1. Irregular reimbursement scenario

6. HEMODYNAMIC MONITORING DEVICES

  • 6.1. INTRODUCTION
    • 6.1.1. BLOOD PRESSURE MONITORS
    • 6.1.2. BLOOD GLUCOSE MONITORS
    • 6.1.3. BLOOD GAS AND ELECTROLYTE ANALYZERS
    • 6.1.4. CHOLESTEROL ANALYZERS

7. NEUROMONITORING DEVICES

  • 7.1. INTRODUCTION
    • 7.1.1. ELECTROENCEPHALOGRAPH (EEG)
    • 7.1.2. TRANSCRANIAL DOPPLER (TCD)
    • 7.1.3. MAGNETOENCEPHALOGRAPH (MEG)
    • 7.1.4. CEREBRAL OXIMETERS
    • 7.1.5. INTRACRANIAL PRESSURE MONITORS (ICP)

8. CARDIAC MONITORING DEVICES

  • 8.1. INTRODUCTION
  • 8.2. ELECTROCARDIOGRAM (ECG)
  • 8.3. ECG MARKET, BY PRODUCT TYPE
    • 8.3.1. RESTING ECG
      • 8.3.1.1. Stress ECG
      • 8.3.1.2. Holter monitor
    • 8.3.2. WIRED HOLTER MONITORS
    • 8.3.3. WIRELESS HOLTER MONITORS
  • 8.4. ECG DEVICES MARKET, BY LEAD TYPE
    • 8.4.1. SINGLE-LEAD ECG DEVICES
    • 8.4.2. 3-6 LEAD ECG DEVICES
    • 8.4.3. 12-LEAD ECG DEVICES
    • 8.4.4. OTHERS
  • 8.5. EVENT MONITORS
  • 8.6. EVENT MONITORS MARKET, BY PRODUCT TYPE
    • 8.6.1. PRE-SYMPTOM (MEMORY LOOP)
    • 8.6.2. POST-SYMPTOM EVENT MONITORS
  • 8.7. EVENT MONITORS MARKET, BY TECHNOLOGY
    • 8.7.1. AUTODETECT MONITORS
    • 8.7.2. MANUAL EVENT MONITOR
  • 8.8. IMPLANTABLE LOOP RECORDER (ILR)
  • 8.9. CARDIAC OUTPUT MONITORING DEVICES
    • 8.9.1. MINIMALLY INVASIVE COM DEVICES
    • 8.9.2. NON-INVASIVE COM DEVICES

9. FETAL AND NEONATAL MONITORING DEVICES

  • 9.1. INTRODUCTION
  • 9.2. ULTRA SOUND FETAL DOPPLERS
  • 9.3. INTERNAL FETAL MONITORS

10. RESPIRATORY MONITORING DEVICES

  • 10.1. INTRODUCTION
  • 10.2. CAPNOGRAPHS
  • 10.3. SPIROMETERS
  • 10.4. ANESTHESIA MONITORS
  • 10.5. SLEEP APNEA MONITORING DEVICES
  • 10.6. PULSE OXIMETERS

11. MULTI-PARAMETER MONITORING DEVICES

  • 11.1. INTRODUCTION
  • 11.2. HIGH-ACUITY MONITORS
  • 11.3. MID-ACUITY MONITORS
  • 11.4. LOW-ACUITY MONITORS

12. REMOTE PATIENT MONITORING DEVICES MARKET

  • 12.1. INTRODUCTION

13. WEIGHT MONITORING DEVICES

  • 13.1. INTRODUCTION

14. TEMPERATURE MONITORING DEVICES

  • 14.1. INTRODUCTION

15. PATIENT MONITORING DEVICES MARKET, BY REGION

  • 15.1. INTRODUCTION
  • 15.2. NORTH AMERICA
  • 15.3. EUROPE
  • 15.4. ASIA-PACIFIC
  • 15.5. REST OF THE WORLD

16. COMPETITIVE LANDSCAPE

  • 16.1. OVERVIEW
  • 16.2. MARKET SHARE ANALYSIS
    • 16.2.1. HEMODYNAMIC MONITORS
      • 16.2.1.1. Blood pressure monitors
      • 16.2.1.2. Single-point blood glucose monitors
      • 16.2.1.3. Continuous blood glucose monitors
      • 16.2.1.4. Blood gas and electrolyte analyzers
    • 16.2.2. NEUROLOGICAL MONITORS
      • 16.2.2.1. Electroencephalographs (EEG)
      • 16.2.2.2. Transcranial Doppler (TCD)
      • 16.2.2.3. Magnetoencephalographs (MEG)
      • 16.2.2.4. Cerebral oximetry monitors
      • 16.2.2.5. Intracranial pressure (ICP) monitors (Top Players)
    • 16.2.3. CARDIAC MONITORS
      • 16.2.3.1. Electrocardiographs (ECG)
      • 16.2.3.2. Event monitors
      • 16.2.3.3. Cardiac output monitors
    • 16.2.4. RESPIRATORY MONITORING DEVICES
      • 16.2.4.1. Capnographs
      • 16.2.4.2. Spirometers
      • 16.2.4.3. Anesthesia monitors
      • 16.2.4.4. Sleep apnea monitors
      • 16.2.4.5. Pulse oximeters
    • 16.2.5. FETAL & NEONATAL MONITORS
    • 16.2.6. MULTI-PARAMETER MONITORS
  • 16.3. COMPETITIVE SITUATION AND TRENDS
    • 16.3.1. NEW PRODUCT LAUNCHES AND APPROVALS
    • 16.3.2. AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS
    • 16.3.3. AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS, 2012-2015
    • 16.3.4. ACQUISITIONS AND EXPANSIONS
    • 16.3.5. OTHER DEVELOPMENTS

17. COMPANY PROFILES*

  • 17.1. INTRODUCTION
  • 17.2. ABBOTT LABORATORIES
  • 17.3. ROCHE DIAGNOSTICS
  • 17.4. SIEMENS HEALTHCARE
  • 17.5. GE HEALTHCARE
  • 17.6. MEDTRONIC PLC
  • 17.7. PHILIPS HEALTHCARE
  • 17.8. LIFEWATCH AG
  • 17.9. NIHON KOHDEN CORPORATION
  • 17.10. OMRON CORPORATION
  • 17.11. HONEYWELL INTERNATIONAL, INC.

*Details On Financials, Products & Services, Key Strategy, & Recent Developments Might Not Be Captured In Case Of Unlisted Companies.

18. APPENDIX

  • 18.1. INSIGHTS OF INDUSTRY EXPERTS
  • 18.2. DISCUSSION GUIDE
  • 18.3. OTHER DEVELOPMENTS
  • 18.4. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 18.5. AVAILABLE CUSTOMIZATIONS
  • 18.6. RELATED REPORTS

LIST OF TABLES

  • TABLE 1: INCREASING GERIATRIC POPULATION TO DRIVE THE PATIENT MONITORING MARKET
  • TABLE 2: DEARTH OF SKILLED PROFESSIONALS IS RESTRAINING THE MARKET GROWTH
  • TABLE 3: PRIVATE INSTITUTIONAL NURSING PROVIDES MARKET GROWTH OPPORTUNITIES
  • TABLE 4: IRREGULAR REIMBURSEMENT SCENARIO: KEY MARKET CHALLENGE
  • TABLE 5: HEMODYNAMIC MONITORING DEVICES MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 6: HEMODYNAMIC MONITORING DEVICES MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 7: BLOOD PRESSURE MONITORS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 8: BLOOD PRESSURE MONITORS MARKET SIZE, BY REGION, 2013-2020 (MILLION UNITS)
  • TABLE 9: BLOOD PRESSURE MONITORS MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION)
  • TABLE 10: BLOOD PRESSURE MONITORS MARKET SIZE, BY SITE OF USAGE, 2013-2020 (USD MILLION)
  • TABLE 11: BLOOD PRESSURE MONITORS MARKET SIZE, BY SITE OF USAGE, 2013-2020 (MILLION UNITS)
  • TABLE 12: BLOOD PRESSURE MONITORS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 13: BLOOD GLUCOSE MONITORS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 14: BLOOD GLUCOSE MONITORS MARKET SIZE, BY REGION, 2013-2020 (MILLION UNITS)
  • TABLE 15: BLOOD GLUCOSE MONITORS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 16: BLOOD GLUCOSE MONITORS MARKET SIZE, BY TYPE, 2013-2020 (MILLION UNITS)
  • TABLE 17: SINGLE-POINT BLOOD GLUCOSE MONITORS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 18: CONTINUOUS BLOOD GLUCOSE MONITORS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 19: BLOOD GLUCOSE MONITORS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 20: BLOOD GAS AND ELECTROLYTE ANALYZERS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 21: BLOOD GAS AND ELECTROLYTE ANALYZERS MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 22: BLOOD GAS AND ELECTROLYTE ANALYZERS MARKET SIZE, BY PRODUCT, 2013-2020 (THOUSAND UNITS)
  • TABLE 23: POC BLOOD GAS AND ELECTROLYTE ANALYZERS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 24: POC BLOOD GAS AND ELECTROLYTE ANALYZERS MARKET SIZE, BY REGION, 2013-2020 (THOUSAND UNITS)
  • TABLE 25: DESKTOP BLOOD GAS AND ELECTROLYTE ANALYZERS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 26: DESKTOP BLOOD GAS AND ELECTROLYTE ANALYZERS MARKET SIZE, BY REGION, 2013-2020 (THOUSAND UNITS)
  • TABLE 27: BLOOD GAS AND ELECTROLYTE ANALYZERS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 28: CHOLESTEROL ANALYZERS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 29: CHOLESTEROL ANALYZERS MARKET SIZE, BY REGION, 2013-2020 (MILLION UNITS)
  • TABLE 30: CHOLESTEROL ANALYZERS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 31: NEUROLOGICAL MONITORING DEVICES MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 32: NEUROMONITORING DEVICES MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 33: EEG DEVICES MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 34: EEG DEVICES MARKET SIZE, BY REGION, 2013-2020 (THOUSAND UNITS)
  • TABLE 35: EEG DEVICES MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 36: TRANSCRANIAL DOPPLER MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 37: TRANSCRANIAL DOPPLER MARKET SIZE, BY REGION, 2013-2020 (NO. OF UNITS)
  • TABLE 38: TRANSCRANIAL DOPPLER MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 39: MAGNETOENCEPHALOGRAPH MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 40: MAGNETOENCEPHALOGRAPH MARKET SIZE, BY REGION, 2013-2020 (NO. OF UNITS)
  • TABLE 41: MAGNETOENCEPHALOGRAPH MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 42: CEREBRAL OXIMETERS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 43: CEREBRAL OXIMETERS MARKET SIZE, BY REGION, 2013-2020 (THOUSAND UNITS)
  • TABLE 44: CEREBRAL OXIMETERS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 45: INTRACRANIAL PRESSURE MONITORS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 46: INTRACRANIAL PRESSURE MONITORS MARKET SIZE, BY REGION, 2013-2020 (THOUSAND UNITS)
  • TABLE 47: INTRACRANIAL PRESSURE MONITORS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 48: CARDIAC MONITORING DEVICES MARKET SIZE, BY PRODUCT, 2015-2020 (USD MILLION)
  • TABLE 49: CARDIAC MONITORING DEVICES MARKET SIZE, BY REGION, 2015-2020 (USD MILLION)
  • TABLE 50: ECG DEVICES MARKET SIZE, BY REGION, 2015-2020 (USD MILLION)
  • TABLE 51: ECG DEVICES MARKET SIZE, BY REGION, 2015-2020 (MILLION UNITS)
  • TABLE 52: ECG DEVICES MARKET SIZE, BY PRODUCT, 2015-2020 (USD MILLION)
  • TABLE 53: ECG DEVICES MARKET SIZE, BY PRODUCT, 2015-2020 (MILLION UNITS)
  • TABLE 54: ECG DEVICES MARKET SIZE, BY LEAD TYPE, 2015-2020 (USD MILLION)
  • TABLE 55: ECG DEVICES MARKET SIZE, BY END USER, 2015-2020 (USD MILLION)
  • TABLE 56: EVENT MONITORS MARKET SIZE, BY REGION, 2015-2020 (USD MILLION)
  • TABLE 57: EVENT MONITORS MARKET SIZE, BY REGION, 2015-2020 (MILLION UNITS)
  • TABLE 58: EVENT MONITORS MARKET SIZE, BY PRODUCT TYPE, 2015-2020 (USD MILLION)
  • TABLE 59: EVENT MONITORS MARKET SIZE, BY PRODUCT TYPE, 2015-2020 (MILLION UNITS)
  • TABLE 60: EVENT MONITORS MARKET SIZE, BY TECHNOLOGY, 2015-2020 (USD MILLION)
  • TABLE 61: EVENT MONITORS MARKET SIZE, BY END USER, 2015-2020 (USD MILLION)
  • TABLE 62: CARDIAC OUTPUT MONITORING DEVICES MARKET SIZE, BY REGION, 2015-2020 (USD MILLION)
  • TABLE 63: CARDIAC OUTPUT MONITORING DEVICES MARKET SIZE, BY REGION, 2015-2020 (MILLION UNITS)
  • TABLE 64: CARDIAC OUTPUT MONITORING DEVICES MARKET SIZE, BY END USER, 2015-2020 (USD MILLION)
  • TABLE 65: FETAL AND NEONATAL MONITORING DEVICES MARKET SIZE, BY REGION, 2015-2020 (USD MILLION)
  • TABLE 66: FETAL AND NEONATAL MONITORING DEVICES MARKET SIZE, BY REGION, 2015-2020 (MILLION UNITS)
  • TABLE 67: FETAL AND NEONATAL MONITORING MARKET SIZE, BY PRODUCT TYPE, 2015-2020 (USD MILLION)
  • TABLE 68: FETAL AND NEONATAL MONITORING MARKET SIZE, BY PRODUCT TYPE, 2015-2020 (MILLION UNITS)
  • TABLE 69: FETAL AND NEONATAL ULTRASOUND DOPPLERS MARKET SIZE, BY REGION, 2015-2020 (USD MILLION)
  • TABLE 70: INTERNAL FETAL MONITORING DEVICES MARKET SIZE, BY REGION, 2015-2020 (USD MILLION)
  • TABLE 71: FETAL AND NEONATAL MONITORING MARKET SIZE, BY APPLICATION, 2015-2020 (USD MILLION)
  • TABLE 72: FETAL AND NEONATAL MONITORING MARKET SIZE, BY END USER, 2015-2020 (USD MILLION)
  • TABLE 73: RESPIRATORY MONITORING DEVICES MARKET SIZE, BY PRODUCT, 2015-2020 (USD MILLION)
  • TABLE 74: RESPIRATORY MONITORING DEVICES MARKET SIZE, BY REGION, 2015-2020 (USD MILLION)
  • TABLE 75: CAPNOGRAPHS MARKET SIZE, BY REGION, 2015-2020 (USD MILLION)
  • TABLE 76: CAPNOGRAPHS MARKET SIZE, BY REGION, 2015-2020 (THOUSAND UNITS)
  • TABLE 77: CAPNOGRAPHS MARKET SIZE, BY TECHNOLOGY, 2015-2020 (USD MILLION)
  • TABLE 78: CAPNOGRAPHS MARKET SIZE, BY PRODUCT, 2015-2020 (USD MILLION)
  • TABLE 79: CAPNOGRAPHS MARKET SIZE, BY PRODUCT, 2015-2020 (THOUSAND UNITS)
  • TABLE 80: CAPNOGRAPHS MARKET SIZE, BY END USER, 2015-2020 (USD MILLION)
  • TABLE 81: SPIROMETERS MARKET SIZE, BY REGION, 2015-2020 (USD MILLION)
  • TABLE 82: SPIROMETERS MARKET SIZE, BY REGION, 2015-2020 (THOUSAND UNITS)
  • TABLE 83: SPIROMETERS MARKET SIZE, BY TECHNOLOGY, 2015-2020 (USD MILLION)
  • TABLE 84: SPIROMETERS MARKET SIZE, BY PRODUCT, 2015-2020 (USD MILLION)
  • TABLE 85: SPIROMETERS DEVICES MARKET SIZE, BY PRODUCT, 2015-2020 (THOUSAND UNITS)
  • TABLE 86: SPIROMETERS MARKET SIZE, BY END USER, 2015-2020 (USD MILLION)
  • TABLE 87: ANESTHESIA MONITORS MARKET SIZE, BY REGION, 2015-2020 (USD MILLION)
  • TABLE 88: ANESTHESIA MONITORS MARKET SIZE, BY REGION, 2015-2020 (THOUSAND UNITS)
  • TABLE 89: ANESTHESIA MONITORS MARKET SIZE, BY PRODUCT, 2015-2020 (USD MILLION)
  • TABLE 90: ANESTHESIA MONITORS MARKET SIZE, BY PRODUCT, 2015-2020 (THOUSAND UNITS)
  • TABLE 91: ANESTHESIA MONITORS MARKET SIZE, BY END USER, 2015-2020 (USD MILLION)
  • TABLE 92: SLEEP APNEA MONITORING DEVICES MARKET SIZE, BY REGION, 2015-2020 (USD MILLION)
  • TABLE 93: SLEEP APNEA MONITORING DEVICES MARKET SIZE, BY REGION, 2015-2020 (THOUSAND UNITS)
  • TABLE 94: SLEEP APNEA MONITORING DEVICES MARKET SIZE, BY PRODUCT, 2015-2020 (USD MILLION)
  • TABLE 95: SLEEP APNEA MONITORING DEVICES MARKET SIZE, BY PRODUCT, 2015-2020 (THOUSAND UNITS)
  • TABLE 96: SLEEP APNEA MONITORING DEVICES MARKET SIZE, BY END USER, 2015-2020 (USD MILLION)
  • TABLE 97: PULSE OXIMETERS MARKET SIZE, BY REGION, 2015-2020 (USD MILLION)
  • TABLE 98: PULSE OXIMETERS MARKET SIZE, BY REGION, 2015-2020 (THOUSAND UNITS)
  • TABLE 99: PULSE OXIMETERS MARKET SIZE, BY PRODUCT, 2015-2020 (USD MILLION)
  • TABLE 100: PULSE OXIMETERS MARKET SIZE, BY PRODUCT, 2015-2020 (THOUSAND UNITS)
  • TABLE 101: PULSE OXIMETERS MARKET SIZE, BY END USER, 2015-2020 (USD MILLION)
  • TABLE 102: MULTI-PARAMETER MONITORING DEVICES MARKET SIZE BY REGION, 2013-2020 (USD MILLION)
  • TABLE 103: MULTI-PARAMETER MONITORING DEVICES MARKET SIZE, BY REGION, 2013-2020 (THOUSAND UNITS)
  • TABLE 104: MULTI-PARAMETER MONITORING DEVICES MARKET SIZE, BY ACUITY, 2013-2020 (USD MILLION)
  • TABLE 105: MULTI-PARAMETER MONITORING DEVICES MARKET SIZE, BY ACUITY, 2013-2020 (THOUSAND UNITS)
  • TABLE 106: MULTI-PARAMETER HIGH-ACUITY MONITORING DEVICES MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 107: MULTI-PARAMETER MID-ACUITY MONITORING DEVICES MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 108: MULTI-PARAMETER LOW-ACUITY MONITORING DEVICES MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 109: MULTI-PARAMETER MONITORING DEVICES MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 110: REMOTE PATIENT MONITORING DEVICES MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 111: REMOTE PATIENT MONITORING DEVICES MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 112: WEIGHT MONITORING DEVICES MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 113: WEIGHT MONITORING DEVICES MARKET SIZE, BY REGION, 2013-2020 (MILLION UNITS)
  • TABLE 114: WEIGHT MONITORING DEVICES MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 115: WEIGHT MONITORING DEVICES MARKET SIZE, BY TYPE, 2013-2020 (MILLION UNITS)
  • TABLE 116: WEIGHT MONITORING DEVICES MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 117: TEMPERATURE MONITORING DEVICES MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 118: TEMPERATURE MONITORING DEVICES MARKET SIZE, BY REGION, 2013-2020 (MILLION UNITS)
  • TABLE 119: TEMPERATURE MONITORING DEVICES MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 120: TEMPERATURE MONITORING DEVICES MARKET SIZE, BY PRODUCT, 2013-2020 (MILLION UNITS)
  • TABLE 121: TEMPERATURE MONITORING DEVICES MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 122: PATIENT MONITORING DEVICES MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 123: NORTH AMERICA: PATIENT MONITORING DEVICES MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 124: NORTH AMERICA: HEMODYNAMIC MONITORING DEVICES MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 125: NORTH AMERICA: NEUROMONITORING DEVICES MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 126: NORTH AMERICA: CARDIAC MONITORING DEVICES MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 127: NORTH AMERICA: FETAL AND NEONATAL MONITORING DEVICES MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 128: NORTH AMERICA: RESPIRATORY AND ANESTHESIA MONITORING DEVICES MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 129: NORTH AMERICA: MULTI-PARAMETER MONITORING DEVICES MARKET SIZE, BY ACUITY, 2013-2020 (USD MILLION)
  • TABLE 130: NORTH AMERICA: OTHER MONITORING DEVICES MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 131: EUROPE: PATIENT MONITORING DEVICES MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 132: EUROPE: HEMODYNAMIC MONITORING DEVICES MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 133: EUROPE: NEUROMONITORING DEVICES MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 134: EUROPE: CARDIAC MONITORING DEVICES MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 135: EUROPE: FETAL AND NEONATAL MONITORING DEVICES MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 136: EUROPE: RESPIRATORY AND ANESTHESIA MONITORING DEVICES MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 137: EUROPE: MULTI-PARAMETER MONITORING DEVICES MARKET SIZE, BY ACUITY, 2013-2020 (USD MILLION)
  • TABLE 138: EUROPE: OTHER MONITORING DEVICES MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 139: ASIA-PACIFIC: PATIENT MONITORING DEVICES MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 140: ASIA-PACIFIC: HEMODYNAMIC MONITORING DEVICES MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 141: ASIA-PACIFIC: NEUROMONITORING DEVICES MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 142: ASIA-PACIFIC: CARDIAC MONITORING DEVICES MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 143: ASIA-PACIFIC: FETAL AND NEONATAL MONITORING DEVICES MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 144: ASIA-PACIFIC: RESPIRATORY AND ANESTHESIA MONITORING DEVICES MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 145: ASIA-PACIFIC: MULTI-PARAMETER MONITORING DEVICES MARKET SIZE, BY ACUITY, 2013-2020 (USD MILLION)
  • TABLE 146: ASIA-PACIFIC: OTHER MONITORING DEVICES MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 147: ROW: PATIENT MONITORING DEVICES MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 148: ROW: HEMODYNAMIC MONITORING DEVICES MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 149: ROW: NEUROMONITORING DEVICES MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 150: ROW: CARDIAC MONITORING DEVICES MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 151: ROW: FETAL AND NEONATAL MONITORING DEVICES MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 152: ROW: RESPIRATORY AND ANESTHESIA MONITORING DEVICES MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 153: ROW: MULTI-PARAMETER MONITORING DEVICES MARKET SIZE, BY ACUITY, 2013-2020 (USD MILLION)
  • TABLE 154: ROW: OTHER MONITORING DEVICES MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 155: MAJOR PLAYERS - MEG, 2014
  • TABLE 156: MAJOR PLAYERS - INTRACRANIAL PRESSURE MONITORS, 2014
  • TABLE 157: SPIROMETERS MARKET: MAJOR PLAYERS, 2014
  • TABLE 158: NEW PRODUCT LAUNCHES & APPROVALS, 2012-2015
  • TABLE 159: ACQUISITIONS AND EXPANSIONS, 2012-2015
  • TABLE 160: OTHER DEVELOPMENTS, 2012-2015

LIST OF FIGURES

  • FIGURE 1: RESEARCH DESIGN
  • FIGURE 2: MARKET SIZE ESTIMATION APPROACH
  • FIGURE 3: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 4: MARKET DATA TRIANGULATION METHODOLOGY
  • FIGURE 5: PATIENT MONITORING DEVICES MARKET SNAPSHOT (2015 VS. 2020)
  • FIGURE 6: ECG DEVICES SEGMENT WILL CONTINUE TO DOMINATE THE MARKET IN THE FORECAST PERIOD
  • FIGURE 7: EEG SEGMENT WILL GROW AT A FASTEST PACE IN THE FORECAST PERIOD
  • FIGURE 8: GEOGRAPHICAL SNAPSHOT: HIGH-GROWTH EXPECTED IN EMERGING MARKETS ACROSS ASIA-PACIFIC DURING THE FORECAST PERIOD
  • FIGURE 9: AGREEMENTS, PARTNERSHIPS & COLLABORATIONS, THE DOMINANT STRATEGIES IN THE MARKET
  • FIGURE 10: CARDIAC MONITORING DEVICES ACCOUNTS FOR THE LARGEST MARKET SHARE IN 2015
  • FIGURE 11: BLOOD PRESSURE MONITORING DEVICES SEGMENT DOMINATES PATIENT MONITORING MARKET IN 2015
  • FIGURE 12: RESTING ELECTROCARDIOGRAM (ECG) DOMINATES ECG SEGMENT
  • FIGURE 13: ELECTROENCEPHALOGRAPH (EEG) SEGMENT TO WITNESS HIGHEST GROWTH IN THE NEUROMONITORING DEVICES MARKET
  • FIGURE 14: RESPIRATORY MONITORING DEVICES MARKET: CAPNOGRAPHY MONITORS WILL REGISTER THE HIGHEST GROWTH RATE
  • FIGURE 15: INCREASING GERIATRIC POPULATION AND INCIDENCE OF LIFESTYLE DISEASES TO DRIVE THE PATIENT MONITORING MARKET GROWTH
  • FIGURE 16: BLOOD PRESSURE MONITORS TO DOMINATE THE HEMODYNAMIC MONITORING DEVICES MARKET IN 2015
  • FIGURE 17: NORTH AMERICA TO WITNESS THE HIGHEST GROWTH IN THE HEMODYNAMIC MONITORING DEVICES MARKET DURING THE FORECAST PERIOD
  • FIGURE 18: NORTH AMERICA TO DOMINATE THE BLOOD PRESSURE MONITORS MARKET IN 2015
  • FIGURE 19: NORTH AMERICA TO WITNESS THE HIGHEST GROWTH IN THE BLOOD GLUCOSE MONITORS MARKET DURING THE FORECAST PERIOD
  • FIGURE 20: NORTH AMERICA TO DOMINATE THE BLOOD GAS AND ELECTROLYTE ANALYZERS MARKET IN 2015
  • FIGURE 21: ASIA-PACIFIC TO WITNESS THE HIGHEST GROWTH IN THE CHOLESTEROL ANALYZERS MARKET DURING THE FORECAST PERIOD
  • FIGURE 22: EEG DEVICES TO DOMINATE THE NEUROLOGICAL MONITORING DEVICES MARKET IN 2015
  • FIGURE 23: ASIA-PACIFIC TO WITNESS HIGHEST GROWTH IN THE NEUROMONITORING DEVICES MARKET DURING THE FORECAST PERIOD
  • FIGURE 24: NORTH AMERICA TO DOMINATE THE ECG DEVICES MARKET IN 2015
  • FIGURE 25: ASIA-PACIFIC REGION TO WITNESS HIGHEST GROWTH IN THE TRANSCRANIAL DOPPLER MARKET
  • FIGURE 26: NORTH AMERICA TO DOMINATE THE MAGNETOENCEPHALOGRAPH MARKET IN 2015
  • FIGURE 27: ASIA-PACIFIC TO WITNESS THE HIGHEST GROWTH IN THE CEREBRAL OXIMETERS MARKET
  • FIGURE 28: NORTH AMERICA IS EXPECTED TO DOMINATE THE INTRACRANIAL PRESSURE MONITORS MARKET IN 2015
  • FIGURE 29: ECG DEVICES SEGMENT EXPECTED TO DOMINATE THE CARDIAC MONITORING DEVICES MARKET IN 2015
  • FIGURE 30: ASIA-PACIFIC ECG MARKET IS EXPECTED TO GROW AT THE HIGHEST RATE DURING THE FORECAST PERIOD
  • FIGURE 31: RESTING MONITORS EXPECTED TO DOMINATE THE MARKET DURING THE FORECAST PERIOD
  • FIGURE 32: 3-6 LEAD TYPE ECG DEVICES EXPECTED TO GROW AT THE HIGHEST RATE DURING THE FORECAST PERIOD
  • FIGURE 33: NORTH AMERICA TO DOMINATE THE EVENT MONITORS MARKET IN 2015
  • FIGURE 34: PRE-EVENT MONITORS ARE EXPECTED TO GROW AT THE HIGHEST RATE DURING THE FORECAST PERIOD
  • FIGURE 35: AUTODETECT EVENT MONITORS TO DOMINATE THE EVENT MONITORING DEVICES MARKET IN 2015
  • FIGURE 36: HOME SEGMENT IS EXPECTED TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 37: NORTH AMERICA TO DOMINATE THE EVENT MONITORS MARKET IN 2015
  • FIGURE 38: HOSPITALS SEGMENT IS EXPECTED TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 39: NORTH AMERICA TO DOMINATE THE FETAL AND NEONATAL MONITORING DEVICES MARKET IN 2015
  • FIGURE 40: FETAL AND NEONATAL ULTRASOUND DOPPLER SEGMENT TO GROW AT THE HIGHEST RATE DURING THE FORECAST PERIOD
  • FIGURE 41: ANESTHESIA MONITORS TO DOMINATE THE RESPIRATORY MONITORING DEVICES MARKET IN 2015
  • FIGURE 42: ASIA-PACIFIC MARKET EXPECTED TO GROW AT THE HIGHEST RATE DURING THE FORECAST PERIOD
  • FIGURE 43: NORTH AMERICA TO DOMINATE THE CAPNOGRAPHS MARKET IN 2015
  • FIGURE 44: ASIA-PACIFIC REGION IS EXPECTED TO GROW AT THE HIGHEST RATE DURING THE FORECAST PERIOD
  • FIGURE 45: NORTH AMERICA TO DOMINATE THE ANESTHESIA MONITORS MARKET IN 2015
  • FIGURE 46: NORTH AMERICA DOMINATES THE MARKET FOR SLEEP APNEA MONITORING DEVICES IN 2015
  • FIGURE 47: NORTH AMERICA DOMINATES THE PULSE OXIMETERS MARKET IN 2015
  • FIGURE 48: NORTH AMERICA DOMINATED THE MULTI-PARAMETER MONITORING DEVICES MARKET IN 2015
  • FIGURE 49: LOW-ACUITY DEVICES DOMINATED THE MULTI-PARAMETER MONITORING MARKET IN 2015
  • FIGURE 50: NORTH AMERICA DOMINATED THE REMOTE PATIENT MONITORING DEVICES MARKET IN 2015
  • FIGURE 51: EUROPE DOMINATED THE GLOBAL WEIGHT MONITORING DEVICES MARKET IN 2015
  • FIGURE 52: NORTH AMERICA DOMINATED THE TEMPERATURE MONITORING DEVICES MARKET IN 2015
  • FIGURE 53: GEOGRAPHIC SNAPSHOT: ASIA-PACIFIC WILL BE THE FASTEST-GROWING REGIONAL SEGMENT IN THE PATIENT MONITORING EQUIPMENT/DEVICES/SYSTEMS MARKET
  • FIGURE 54: ASIA-PACIFIC MARKET FOR PATIENT MONITORING DEVICES TO OFFER SIGNIFICANT GROWTH OPPORTUNITIES
  • FIGURE 55: NORTH AMERICA WILL CONTINUE TO DOMINATE THE PATIENT MONITORING DEVICES MARKET IN THE FORECAST PERIOD
  • FIGURE 56: NORTH AMERICA: PATIENT MONITORING DEVICES MARKET SNAPSHOT
  • FIGURE 57: NEUROMONITORING DEVICES SEGMENT TO WITNESS HIGHEST GROWTH IN THE NORTH AMERICAN PATIENT MONITORING DEVICES MARKET
  • FIGURE 58: CARDIAC MONITORING DEVICES WILL CONTINUE TO DOMINATE THE EUROPEAN PATIENT MONITORING DEVICES MARKET
  • FIGURE 59: ASIA-PACIFIC: PATIENT MONITORING DEVICES MARKET SNAPSHOT
  • FIGURE 60: RPM DEVICES SEGMENT TO WITNESS THE HIGHEST GROWTH IN THE APAC PATIENT MONITORING DEVICES MARKET
  • FIGURE 61: CARDIAC MONITORING DEVICES WILL CONTINUE TO DOMINATE THE PATIENT MONITORING DEVICES MARKET IN THE REST OF THE WORLD REGION
  • FIGURE 62: NEW PRODUCT LAUNCHES & APPROVALS WAS THE KEY GROWTH STRATEGY ADOPTED BY PLAYERS IN THE LAST THREE YEARS (2012-2015)
  • FIGURE 63: GLOBAL BLOOD PRESSURE MONITORS MARKET SHARE, BY KEY PLAYER, 2014
  • FIGURE 64: GLOBAL SINGLE-POINT BLOOD GLUCOSE MONITORS MARKET SHARE, BY KEY PLAYER, 2014
  • FIGURE 65: GLOBAL CONTINUOUS BLOOD GLUCOSE MONITORS MARKET SHARE, BY KEY PLAYER, 2014
  • FIGURE 66: GLOBAL BLOOD GAS & ELECTROLYTE ANALYZERS MARKET SHARE, BY KEY PLAYER, 2014
  • FIGURE 67: GLOBAL EEG MARKET SHARE, BY KEY PLAYER, 2014
  • FIGURE 68: GLOBAL TCD MARKET SHARE, BY KEY PLAYER, 2014
  • FIGURE 69: GLOBAL CEREBRAL OXIMETRY MONITORS MARKET SHARE, BY KEY PLAYER, 2014
  • FIGURE 70: GLOBAL ECG MARKET SHARE, BY KEY PLAYER, 2014
  • FIGURE 71: GLOBAL EVENT MONITORS MARKET SHARE, BY KEY PLAYER, 2014
  • FIGURE 72: GLOBAL CARDIAC MONITORS MARKET SHARE, BY KEY PLAYER, 2014
  • FIGURE 73: GLOBAL CAPNOGRAPHS MARKET SHARE, BY KEY PLAYER, 2014
  • FIGURE 74: GLOBAL ANESTHESIA MONITORS MARKET SHARE, BY KEY PLAYER, 2014
  • FIGURE 75: GLOBAL SLEEP APNEA MONITORS MARKET SHARE, BY KEY PLAYER, 2014
  • FIGURE 76: GLOBAL PULSE OXIMETERS MARKET SHARE, BY KEY PLAYER, 2014
  • FIGURE 77: GLOBAL FETAL & NEONATAL MONITORS MARKET SHARE, BY KEY PLAYER, 2014
  • FIGURE 78: GLOBAL MULTI-PARAMETER MONITORS MARKET SHARE, BY KEY PLAYER, 2014
  • FIGURE 79: BATTLE FOR MARKET SHARE: NEW PRODUCT LAUNCHES AND APPROVALS WAS THE KEY GROWTH STRATEGY
  • FIGURE 80: GEOGRAPHIC REVENUE MIX OF THE TOP FIVE MARKET PLAYERS
  • FIGURE 81: ROCHE DIAGNOSTICS: COMPANY SNAPSHOT
  • FIGURE 82: SIEMENS HEALTHCARE: COMPANY SNAPSHOT
  • FIGURE 83: KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT
  • FIGURE 84: LIFEWATCH AG: COMPANY SNAPSHOT
  • FIGURE 85: NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT
  • FIGURE 86: OMRON CORPORATION: COMPANY SNAPSHOT
  • FIGURE 87: HONEYWELL INTERNATIONAL, INC.: COMPANY SNAPSHOT
Back to Top